FINANCIAL NEWS

UAE’s Julphar profit improves 14.9 percent in 2013

24 Feb 2014

(MENAFN) Julphar, Ras Al Khaimah-based pharmaceutical products producer and distributor, reported a 14.9 percent growth in net profit of 2013 to reach USD62.71 million, according to the Emirates 24/7.

The company also reported a 15.4 percent growth in revenue year-on-year to reach USD3707 million.

Sales boosted by 19.4 percent year-on-year in 2013 driven by the private market sales.

Julphar Chairman, Sheikh Faisal Bin Saqr Al Qassimi, said: “The UAE is driving forward healthcare expansion at an international level and Julphar is proud to play a significant role in shaping the future of our industry. As the first and largest Emirati Pharmaceutical Company, we are positioned to help create a truly global platform for quality healthcare.”

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more